Badin J, Denne M A
J Clin Pathol. 1976 Nov;29(11):984-90. doi: 10.1136/jcp.29.11.984.
A reagent made of zinc sulphate (0-08 M) in a 0-4 M sodium salicylate solution at pH 7-3 precipitated most of the IgG when a small volume of human serum was added. Sera with normal IgG levels or polyclonal hyperglobulinaemia showed a close correlation between total IgG and zinc-precipitated IgG (r = + 0-95). In clinical material, not including IgG myeloma, zinc-soluble IgG varied between 0 and 6 mg/ml and was independent of the IgG serum concentration. In 31 normal subjects the average IgG concentration, as determined by the Technicon immunonephelometric method, was 10-2 +/- 1-7 mg/ml for total IgG and 2-2 +/- 1-0 mg/ml for the soluble fraction. Among 173 sera, including 24 from cord blood, 16 from pregnant women, and 133 from patients with miscellaneous diseases, no pathological conditions except three cases of IgG myeloma were found with a zinc-soluble IgG definitely above the normal values; zinc-soluble IgG levels were often low in patients with hyperglobulinaemia, and the difference was highly significant in liver disease. kappa and gamma light chains as well as the four IgG-Hp chain subclasses were found in both zinc-soluble fractions of normal IgG. A study of myeloma monoclonal IgG showed that globulins of classes 1, 3, and 4 could be either soluble or insoluble in the zinc reagent. One, G2, was mainly insoluble. Hexose and antistreptolysin contents per milligram normal IgG were not significantly different in either fraction. It is suggested that zinc-soluble IgG consists of the recently synthesized molecules, the zinc-solubility of which has not yet been decreased by protein association, lipid interaction, antigen binding, or enzymatic denaturation. Within this hypothesis, a low level of soluble IgG would mean either an increased precatabolic protein or a decreased synthesis.
由硫酸锌(0.08M)溶于pH值为7.3的0.4M水杨酸钠溶液制成的一种试剂,当加入少量人血清时,可沉淀出大部分IgG。IgG水平正常或患有多克隆高球蛋白血症的血清,其总IgG与锌沉淀IgG之间呈现密切相关性(r = +0.95)。在不包括IgG骨髓瘤的临床样本中,锌溶性IgG在0至6mg/ml之间变化,且与IgG血清浓度无关。采用Technicon免疫比浊法测定,31名正常受试者的总IgG平均浓度为10.2±1.7mg/ml,可溶性部分的平均浓度为2.2±1.0mg/ml。在173份血清中,包括24份脐血、16份孕妇血清和133份患有各种疾病患者的血清,除3例IgG骨髓瘤外,未发现锌溶性IgG明显高于正常值的病理状况;高球蛋白血症患者的锌溶性IgG水平常常较低,在肝病患者中差异极为显著。在正常IgG的两种锌溶性部分中均发现了κ和γ轻链以及四种IgG-Hp链亚类。对骨髓瘤单克隆IgG的研究表明,1、3和4类球蛋白在锌试剂中既可以是可溶的,也可以是不可溶的。一种G2类球蛋白主要是不可溶的。每毫克正常IgG的己糖和抗链球菌溶血素含量在任何一种组分中均无显著差异。有人提出,锌溶性IgG由最近合成的分子组成,其锌溶性尚未因蛋白质结合、脂质相互作用、抗原结合或酶促变性而降低。基于这一假设,可溶性IgG水平较低意味着要么分解代谢前的蛋白质增加,要么合成减少。